Skip to content

Clinical trials

Completed Multiple Sclerosis, Relapsing-Remitting trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Status: Completed Country / region: Spain Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20074
20081
20094
20103
20114
20135
20143
20156
20162
20182
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen10
Genzyme, a Sanofi Company4
Novartis Pharmaceuticals4
Bayer3
GlaxoSmithKline3
Hoffmann-La Roche2
Tanabe Pharma Corporation2
Universidad de Almeria2
Banc de Sang i Teixits1
EMD Serono1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting39
Multiple Sclerosis19
Recurrence3
Demyelinating Diseases2
Fatigue2
Multiple Sclerosis, Chronic Progressive2
Anxiety Disorders1
Autoimmune Diseases1
Cognitive Dysfunction1
Diffuse Cerebral Sclerosis of Schilder1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.